Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal nicotine for motor symptoms in advanced Parkinson's disease
2008-001336-13Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of nicotine in Parkinson's disease (PD) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Change in UPDRS part III motor score. Started Jun 2008; status: active.
02
Drugs
nicotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2008-001336-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001336-13.